Journal: Eye (London, England)

Article Title: Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents.

PMID/MRN: 27716750

Publication Date: 2016-Oct-07

Abstract:

Anti-vascular endothelial growth factor (VEGF) intravitreal agents are the only successful treatment for wet age-related macular degeneration (AMD). However, there are emerging signals that anti-VEGF treatment can potentially increase development of geographic atrophy (GA). Histopathologic, animal, and clinical studies support this hypothesis although direct proof of a relationship between GA and use of anti-VEGF agents in neovascular AMD is not yet established. This review presents current evidence supporting an association between anti-VEGF therapy and progression of geographic atrophy. The need of exploring alternative methods of treating AMD is indirectly but clearly emphasized.Eye advance online publication, 7 October 2016; doi:10.1038/eye.2016.208.